These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32147052)

  • 1. Autonomically-mediated decrease in microvascular blood flow due to mental stress and pain in sickle cell disease: A target for neuromodulatory interventions.
    Martin SR; Shah P; Denton C; Zeltzer LK; Veluswamy S; Khoo MCK; Coates TD
    Complement Ther Med; 2020 Mar; 49():102334. PubMed ID: 32147052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of hypnosis on pain and peripheral blood flow in sickle-cell disease: a pilot study.
    Bhatt RR; Martin SR; Evans S; Lung K; Coates TD; Zeltzer LK; Tsao JC
    J Pain Res; 2017; 10():1635-1644. PubMed ID: 28769584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mental stress causes vasoconstriction in subjects with sickle cell disease and in normal controls.
    Shah P; Khaleel M; Thuptimdang W; Sunwoo J; Veluswamy S; Chalacheva P; Kato RM; Detterich J; Wood JC; Zeltzer L; Sposto R; Khoo MCK; Coates TD
    Haematologica; 2020 Jan; 105(1):83-90. PubMed ID: 30975906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individuals with sickle cell disease have a significantly greater vasoconstriction response to thermal pain than controls and have significant vasoconstriction in response to anticipation of pain.
    Khaleel M; Puliyel M; Shah P; Sunwoo J; Kato RM; Chalacheva P; Thuptimdang W; Detterich J; Wood JC; Tsao J; Zeltzer L; Sposto R; Khoo MCK; Coates TD
    Am J Hematol; 2017 Nov; 92(11):1137-1145. PubMed ID: 28707371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biophysical markers of the peripheral vasoconstriction response to pain in sickle cell disease.
    Chalacheva P; Khaleel M; Sunwoo J; Shah P; Detterich JA; Kato RM; Thuptimdang W; Meiselman HJ; Sposto R; Tsao J; Wood JC; Zeltzer L; Coates TD; Khoo MCK
    PLoS One; 2017; 12(5):e0178353. PubMed ID: 28542469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoconstriction Response to Mental Stress in Sickle Cell Disease: The Role of the Cardiac and Vascular Baroreflexes.
    Thuptimdang W; Shah P; Khaleel M; Sunwoo J; Veluswamy S; Kato RM; Coates TD; Khoo MCK
    Front Physiol; 2021; 12():698209. PubMed ID: 34803725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive vasoconstriction with sequential thermal stimulation indicates vascular dysautonomia in sickle cell disease.
    Veluswamy S; Shah P; Khaleel M; Thuptimdang W; Chalacheva P; Sunwoo J; Denton CC; Kato R; Detterich J; Wood JC; Sposto R; Khoo MCK; Zeltzer L; Coates TD
    Blood; 2020 Sep; 136(10):1191-1200. PubMed ID: 32518948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell Disease.
    Puri L; Nottage KA; Hankins JS; Anghelescu DL
    Paediatr Drugs; 2018 Feb; 20(1):29-42. PubMed ID: 28853040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conjunctival microvascular hemodynamics following vaso-occlusive crisis in sickle cell disease.
    Kord Valeshabad A; Wanek J; Gaynes B; Saraf SL; Molokie R; Shahidi M
    Clin Hemorheol Microcirc; 2015 Sep; 62(4):359-67. PubMed ID: 26444608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting novel mechanisms of pain in sickle cell disease.
    Tran H; Gupta M; Gupta K
    Blood; 2017 Nov; 130(22):2377-2385. PubMed ID: 29187376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Electronic Teaching Module for Improving Knowledge of Self-Management of Vaso-Occlusive Pain Crises in Patients With Sickle Cell Disease: Pilot Questionnaire Study.
    Tam T; Baer MR; Hsu LL; Law JY
    JMIR Mhealth Uhealth; 2019 Jun; 7(6):e13501. PubMed ID: 31223120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autonomic nervous system involvement in sickle cell disease.
    Coates TD; Chalacheva P; Zeltzer L; Khoo MCK
    Clin Hemorheol Microcirc; 2018; 68(2-3):251-262. PubMed ID: 29614636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which side of the balance determines the frequency of vaso-occlusive crises in children with sickle cell anemia: Blood viscosity or microvascular dysfunction?
    Charlot K; Romana M; Moeckesch B; Jumet S; Waltz X; Divialle-Doumdo L; Hardy-Dessources MD; Petras M; Tressières B; Tarer V; Hue O; Etienne-Julan M; Antoine-Jonville S; Connes P
    Blood Cells Mol Dis; 2016 Jan; 56(1):41-5. PubMed ID: 26603723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospitalist management of vaso-occlusive pain crisis in patients with sickle cell disease using a pathway of care.
    Allen Liles E; Kirsch J; Gilchrist M; Adem M
    Hosp Pract (1995); 2014 Apr; 42(2):70-6. PubMed ID: 24769786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nocturnal peripheral vasoconstriction predicts the frequency of severe acute pain episodes in children with sickle cell disease.
    Chalacheva P; Ji Y; Rosen CL; DeBaun MR; Khoo MCK; Coates TD
    Am J Hematol; 2021 Jan; 96(1):60-68. PubMed ID: 33027545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurocognitive and psychological effects of persistent pain in pediatric sickle cell disease.
    Connolly ME; Bills SE; Hardy SJ
    Pediatr Blood Cancer; 2019 Sep; 66(9):e27823. PubMed ID: 31131984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart rate variability study in adult Nigerian subjects with sickle cell disease during vaso-occlusive crisis.
    Adebiyi AA; Oyebowale OM; Olaniyi AJ; Falase AO
    Niger Postgrad Med J; 2019; 26(1):8-12. PubMed ID: 30860193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychosocial and pharmacological management of pain in pediatric sickle cell disease.
    Hildenbrand AK; Nicholls EG; Daly BP; Marsac ML; Tarazi R; Deepti R
    Postgrad Med; 2014 Mar; 126(2):123-33. PubMed ID: 24685976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between frequency and severity of vaso-occlusive crises and health-related quality of life and work productivity in adults with sickle cell disease.
    Rizio AA; Bhor M; Lin X; McCausland KL; White MK; Paulose J; Nandal S; Halloway RI; Bronté-Hall L
    Qual Life Res; 2020 Jun; 29(6):1533-1547. PubMed ID: 31933113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of patient-reported vaso-occlusive crisis day as an endpoint in sickle cell disease studies.
    Eur J Haematol; ; . PubMed ID: 35569114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.